Rare diseases
Investigational molecules
Locations
Back to Denmark184 clinical trials in Vejle, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer
DenmarkStudy Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
DenmarkDenmarkStudy on Epinephrine and Amiodarone for Patients with Cardiac Arrest Outside the Hospital
DenmarkStudy on Spinal vs. General Anaesthesia with Ropivacaine Hydrochloride for Osteoarthritis Patients Undergoing Hip and Knee Replacement
DenmarkStudy to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
DenmarkStudy of LY3819469 for Adults with High Lipoprotein(a) Levels
DenmarkStudy of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma
DenmarkStudy on the Safety of Ibuprofen for Patients Experiencing Pain After Hip and Knee Replacement Surgery
DenmarkStudy Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients
DenmarkDenmarkStudy of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on advanced treatments for various cancer types, particularly metastatic prostate cancer, chronic lymphocytic leukemia, and colorectal cancer. Studies are evaluating innovative therapies and treatment combinations.
Research emphasizes personalized treatment approaches and novel drug combinations to improve patient outcomes.
Investigations into treatments for chronic inflammatory conditions, including rhinosinusitis, psoriatic arthritis, and inflammatory bowel diseases. Studies are evaluating biologic therapies and their optimal usage.
Focus on developing targeted therapies and understanding treatment duration optimization.
Research into respiratory conditions, particularly focusing on severe asthma and viral lung infections. Studies are examining new therapeutic approaches and treatment effectiveness.
Emphasis on developing innovative treatments for patients with difficult-to-control respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
